Polysaccharides regulate Th1/Th2 balance: A new strategy for tumor immunotherapy

Biomed Pharmacother. 2024 Jan:170:115976. doi: 10.1016/j.biopha.2023.115976. Epub 2023 Dec 3.

Abstract

T helper (Th) cells have received extensive attention owing to their indispensable roles in anti-tumor immune responses. Th1 and Th2 cells are two key subsets of Th cells that exist in relative equilibrium through the secretion of cytokines that suppress their respective immune response. When the type of cytokine in the tumor microenvironment is altered, this equilibrium may be disrupted, leading to a shift from Th1 to Th2 immune response. Th1/Th2 imbalance is one of the decisive factors in the development of malignant tumors. Therefore, focusing on the balance of Th1/Th2 anti-tumor immune responses may enable future breakthroughs in cancer immunotherapy. Polysaccharides can regulate the imbalance between Th1 and Th2 cells and their characteristic cytokine profiles, thereby improving the tumor immune microenvironment. To our knowledge, this study is the most comprehensive assessment of the regulation of the tumor Th1/Th2 balance by polysaccharides. Herein, we systematically summarized the intrinsic molecular mechanisms of polysaccharides in the regulation of Th1 and Th2 cells to provide a new perspective and potential target drugs for improved anti-tumor immunity and delayed tumor progression.

Keywords: Cytokines; Polysaccharide; Th1/Th2 balance; Tumor immune microenvironment.

Publication types

  • Review

MeSH terms

  • Cytokines
  • Humans
  • Immunotherapy
  • Neoplasms* / drug therapy
  • Polysaccharides / therapeutic use
  • Th1 Cells*
  • Th2 Cells
  • Tumor Microenvironment

Substances

  • Cytokines
  • Polysaccharides